Biotech · Private company · Menlo Park, CA, US
Eclipse Enterogenesis, Inc.
Track this companyFree. Adds Eclipse Enterogenesis, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patientsFiscal year 2026 · $860.9KNIH RePORTER 5R44DK127658-05 · fetched Nov 12, 2026
- Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patientsFiscal year 2025 · $856.7KNIH RePORTER 2R44DK127658-04 · fetched Nov 12, 2026